Connect with us

Hi, what are you looking for?

Monday, Mar 27, 2023
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


New ‘CB2’ oil is superior to CBD: Cannanda

Company claims the extract has better bioavailability, a higher success rate and is perfectly legal to travel with internationally

New 'CB2' oil is superior to CBD: Cannanda
Photo via Cannanda.

A Canadian natural health product company claims to have formulated a hemp extract with superior qualities in comparison to the more widely known cannabis-derived health remedy, CBD.

On Monday, Cannanda released statements and a list of characteristics attributable to its terpene-based CB2 oil product.

The company claims the extract is a safer alternative to CBD that has been offering fast relief for thousands of Canadian citizens.

Read more: PHCO2 launches potent and patented ‘Aquazome’ CBD extract

Read more: CBD legalization worldwide shaping up the market’s future growth: Frost & Sullivan

“The benefit of CB2 oil is that it side-steps every problem that plagues CBD; problems like adverse drug interactions, unanswered questions regarding safety, undisclosed THC, and other quality issues. CB2 oil also has double the success rate compared to CBD, and has a much more direct benefit on pain, arthritis, and other inflammatory conditions,” said Lee Know, co-founder of Cannanda.

Cannanda says that its CB2 extract does not cause adverse drug interactions/reactions like CBD can when a consumer is taking various medications, which is potentially dangerous. The company also claims the product is far less expensive than CBD merchandise.

The extract producer says CB2 is a safer alternative to CBD for athletes and employees who may be subject to drug testing due to the fact that CBD products can often have an undisclosed amount of THC in them due to inadequate quality control measures.

CB2 has 100 per cent GRAS status, according to the company, meaning that it is generally recognized as safe by the FDA. Cannanda says that CBD has had that status revoked.

It also has a 60-70 per cent success rate (roughly 2/3 people find that it works) and the company claims that CBD only has a 33 per cent success rate. Additionally, it has superior bioavailability when compared to the poor absorption of CBD, and the company also claims that it activates “CB2 receptors” in the body whereas CBD does not activate any receptors.


Follow Mugglehead on Twitter

Like Mugglehead on Facebook












Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


The government is investing an additional $3 million in 2023–24 and $3 million in 2024–25 into this program


'SANA-013' is a proprietary therapy intended to treat conditions like migraines, episodic cluster headaches and MDD

Stock News

The company is planning an internal reorganization to meet the eligibility criteria and minimum requirements for listing


An independent study in B.C. found concerning numbers and pot sold in other provinces was also found to be mislabelled